T L Schwinghammer
Overview
Explore the profile of T L Schwinghammer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haselberger M, Schwinghammer T
Ann Pharmacother
. 1995 Sep;
29(9):918-21.
PMID: 8547741
For these reasons, a definitive statement about the relative efficacy of mesna for prophylaxis of cyclophosphamide-associated HC in BMT patients cannot be made. Because HC is a frequent and potentially...
2.
Schwinghammer T, Bloom E, Rosenfeld C, Wilson J, Przepiorka D, Shadduck R
Bone Marrow Transplant
. 1995 Jul;
16(1):147-54.
PMID: 7581115
Twenty-eight consecutive recipients of HLA-identical sibling marrow grafts received prophylaxis for GVHD with high-dose cyclosporine (CsA) and corticosteroids. CsA 5 mg/kg/day (2.5 mg/kg infused over 4 h twice daily) was...
3.
4.
Schwinghammer T, Wiggins L, Burgunder M, Michell T, BAILEY W
Am J Hosp Pharm
. 1994 Oct;
51(19):2419-21.
PMID: 7847409
No abstract available.
5.
Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation
Schwinghammer T, Bloom E
Clin Pharm
. 1993 Oct;
12(10):736-61.
PMID: 8258255
The immunology, pathophysiology, incidence, clinical manifestations, grading, and prevention of acute graft-versus-host disease (GVHD) are reviewed. GVHD occurs after allogeneic marrow transplantation when immunologically competent T lymphocytes in the donor...
6.
Schwinghammer T, Fleming R, Rosenfeld C, Przepiorka D, Shadduck R, Bloom E, et al.
Cancer Chemother Pharmacol
. 1993 Jan;
32(4):273-8.
PMID: 8324869
Total and unbound etoposide pharmacokinetics were studied in 16 adult patients (median age, 34 years; range, 18-61 years) undergoing autologous bone marrow transplantation for advanced lymphoma after receiving high-dose etoposide...
7.
Schwinghammer T, Young B, Hirsh J
Am J Hosp Pharm
. 1992 Dec;
49(12):2939-43.
PMID: 1481797
The results of a drug-use evaluation (DUE) of triazolam at a university medical center are reported. The DUE was conducted at three institutions in a medical center complex with over...
8.
Gilliand B, Stanislav G, Constantin J, Schwinghammer T
Am J Hosp Pharm
. 1992 Apr;
49(4):860-3.
PMID: 1595723
A program for reviewing medication doses returned to the pharmacy department is described. Discrepancies concerning returned doses at a teaching hospital led to the creation of a returned-dose log sheet....
9.
Schwinghammer T, Przepiorka D, Venkataramanan R, Wang C, Burckart G, Rosenfeld C, et al.
Br J Clin Pharmacol
. 1991 Sep;
32(3):323-8.
PMID: 1777368
1. The pharmacokinetics of cyclosporine (CsA) and the time course of CsA metabolites were studied in five bone marrow transplant patients after intravenous (i.v.) administration on two separate occasions and...
10.
Schwinghammer T, Antal E, Kubacka R, Hackimer M, Johnston J
Clin Pharm
. 1991 Jul;
10(7):532-8.
PMID: 1907234
The pharmacokinetics and pharmacodynamics of glyburide were studied in elderly and young nondiabetic adults. Healthy nondiabetic men and women 18-40 years of age (young subjects) and 60-85 years of age...